The role of serum total ghrelin level elevation in colon cancer patients

Journal of B.U.ON.

Volumn 19, Issue 2, 2014, Pages 388-393

  Nikolopoulos, Dimitrios ^a   Theocharis, Stamatios ^b   Moutsios Rentzos, Andreas ^c   Kouraklis, Gregorios ^a   Kostakis, Alcibiades ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF THE AEGEAN   (Greece)

Author keywords

Cell differentiation; Cell proliferation; Colon cancer; Ghrelin

Indexed keywords

GHRELIN;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CANCER LOCALIZATION; CANCER PATIENT; CANCER SIZE; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL PRACTICE; COLON CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENDER; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; FEMALE; GHRELIN; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS;

EID: 84904167812     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Kojima M, Hosoda H, Date Y et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402:656-660. (Pubitemid 129516334)
2. Kojima M, Hosoda H, Matsuo H et al. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab 2001;3:118-122. (Pubitemid 33714199)
3. Kojima M, Hosoda H, Kangawa K. Ghrelin, a novel growth hormone- releasing and appetite-stimulating peptide from stomach. Best Pract Res Clin Endocrinol Metab 2004;18:517-530. (Pubitemid 39485216)
4. Korbonits M, Goldstone AP, Gueorguiev M et al. Ghrelin - a hormone with multiple functions. Front Neuoendocrinol 2004;25:27-68. (Pubitemid 38737393)
5. Nikolopoulos D, Theocharis S, Kouraklis G. Ghrelin: a potential therapeutic target for cancer. Regul Pept 2010;163:7-17.
6. Diaz-Lezama N, Hernández-Elvira M, Sandoval A et al. Ghrelin inhibits proliferation and increases T-type Ca2+ channel expression in PC-3 human prostate carcinoma cells. Biochem Biophys Res Commun 2010; 403:24-29.
7. Murphy G, Kamangar F, Dawsey SM et al. The relationship between serum ghrelin and the risk of gastrio and esophagogastric junctional adenocarcinomas. J Natl Cancer Inst 2011;103:1123-1129.
8. Hiura Y, Takiguchi S, Yamamoto K et al. Fall in plasma ghrelin concentrations after cisplatin-based chemotherapy in esophageal cancer patients. Int J Clin Oncol 2012;17:316-323.
9. Nikolopoulos D, Theocharis S, Kouraklis G. Ghrelin's role on gastrointestinal tract cancer. Surg Oncol 2010; 19:e2-e10.
10. Qi Huang, Yue-Zu Fan, Bu-Jun Ge et al. Circulating Ghrelin in Patients with Gastric or Colorectal Cancer. Dig Dis Sci 2007;52:803-809.
11. D'Onghia V, Leoncini R, Carli R et al. Circulating gastrin and ghrelin levels in patients with colorectal cancer: Correlation with tumor stage, Helicobacter pylori infection and BMI. Biomed Pharmacother 2007; 61:137-141. (Pubitemid 46561187)
12. An JY, Min-Gew Ch, Jae HN et al. Clinical significance of ghrelin concentration of plasma and tumor tissue in patients with gastric cancer. J Surg Res 2007;143:344-349. (Pubitemid 350101578)
13. Takahashi M, Terashima M, Takagane A et al. Ghrelin and leptin levels in cachectic patients with cancer of the digestive organs. Int J Clin Oncol 2009;14:315-320.
14. Waseem T, Javaid-ur-Rehman, Ahmad F et al. Role of ghrelin axis in colorectal cancer: a novel association. Peptides 2008; 29:1369-1376.
15. Corbetta S, Peracchi M, Cappiello V et al. Circulating ghrelin levels in patients with pancreatic and gastrointestinal neuroendocrine tumors: identification of one pancreatic ghrelinoma. J Clin Endocrinol Metab 2003;88:3117-3120. (Pubitemid 36877481)
16. Murata M, Okimura Y, Iida K et al. Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. J Biol Chem 2002;277:5667-5774.
17. Ataseven H, Bahcecioglu IH, Kuzu N et al. The levels of ghrelin, leptin, TNF-alpha, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection. Mediators Inflamm 2006:78380.
18. Morpurgo PS, Cappiello V, Verga U et al. Ghrelin in human medullary thyroid carcinomas. Clin Endocrinol (Oxf) 2005;63:437-441. (Pubitemid 41442338)
19. Wolf I, Sadetzki S, Kanety H et al. Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Cancer 2006;106:966-773.
20. Karapanagiotou EM, Polyzos A, Dilana KD et al. Increased serum levels of ghrelin at diagnosis mediate body weight loss in non-small cell lung cancer (NSCLC) patients. Lung Cancer 2009;66:393-398.
21. Mungan NA, Eminferzane S, Mungan AG et al. Diagnostic value of serum ghrelin levels in prostate cancer. Urol Int 2008;80:245-248. (Pubitemid 351693071)
22. Bertaccini A, Pernetti R, Marchiori D et al. Variations in blood ghrelin levels in prostate cancer patients submitted to hormone suppressive treatment. Anticancer Res 2009;29:1345-1348.
23. Malendowicz W, Ziolkowska A, Szyszka M et al. Elevated blood active ghrelin and unaltered total ghrelin and obestatin concentrations in prostate carcinoma. Urol Int 2009; 83:471-475.
24. Markowska A, Ziółkowska A, Jaszczyńska-Nowinka K et al. Elevated blood plasma concentrations of active ghrelin and obestatin in benign ovarian neoplasms and ovarian cancers. Eur J Gynaecol Oncol 2009;30:518-522.
25. Cappiello V, Ronchi C, Morpurgo PS et al. Circulating ghrelin levels in basal conditions and during glucose tolerance test in acromegalic patients. Eur J Endocrinol 2002;147:189-194.
26. Moschovi M, Trimis G, Vounatsou M et al. Serial plasma concentrations of PYY and ghrelin during chemotherapy in children with acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2008;30:733-737.
27. Nanzer AM, Khalaf S, Mozid AM et al. Ghrelin exerts a proliferative effect on a rat pituitary somatotroph cell line via the mitogen-activated protein kinase pathway. Eur J Endocrinol 2004;151:233-240. (Pubitemid 39207019)
28. Freeman HJ. Risk of gastrointestinal malignancies and mechanisms of cancer development with obesity and its treatment Best Pract Res Clin Gastroenterol 2004;18:1167-1175. (Pubitemid 39517699)
29. Lawnicka H, Mełeń-Mucha G, Motylewska E et al. Modulation of ghrelin axis influences the growth of colonic and prostatic cancer cells in vitro. Pharmacol Rep 2012;64:951-959.
30. Wang Z, Wang W, Qiu W et al. Involvement of ghrelin-growth hormone secretagogue receptor system in pathoclinical profiles of digestive system cancer. Acta Biochim Biophys Sin 2007;39:992-998. (Pubitemid 350274289)
31. Shimizu Y, Nagaya N, Isobe T et al. Increased plasma ghrelin level in lung cancer cachexia. Clin Cancer Res 2003;9:774-778. (Pubitemid 36182614)
32. Garcia JM, Garcia-Touza M, Hijazi RA et al. Active ghrelin levels and active to total ghrelin ratio in cancer-induced cachexia. J Clin Endocrinol Metab 2005;90:2920-2926. (Pubitemid 40686344)
33. Madeddu C, Maccio A, Mantovani G. Multitargeted treatment of cancer cachexia. Crit Rev Oncol 2012; 17:305-314.
34. Argilés JM, Stemmler B. The potential of ghrelin in the treatment of cancer cachexia. Expert Opin Biol Ther 2013;13:67-76.
35. Fujitsuka N, Asakawa A, Amitani H et al. Efficacy of ghrelin in cancer cachexia: clinical trials and a novel treatment by rikkunshito. Crit Rev Oncol 2012;17:277-284.